logo
Select company
Select metric
$ -119.51MConsolidated Income
VS
Market
10
Sector
19
Industry
25
History
73
$ 5.87Close
$ 1.06 - $ 6.45 52-Week Range
Ticker Information

Ticker

ATAI

Company Name

ATAI LIFE SCIENCES NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATAI LIFE SCIENCES NV - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATAI - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -119.51M
3/31/2025$ -149.14M
12/31/2024$ -150.05M
9/30/2024$ -130.2M
6/30/2024$ -60.52M
3/31/2024$ -36.92M
12/31/2023$ -43.9M
9/30/2023$ -71.4M
6/30/2023$ -150.47M
3/31/2023$ -154.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATAI LIFE SCIENCES NV's latest trailing twelve months (TTM) Cons. Inc. stands at $ -178.63M.
  • Over the past 5 years, ATAI LIFE SCIENCES NV's average Cons. Inc. has been $ -137.28M.
  • The median Cons. Inc. for ATAI LIFE SCIENCES NV during this period was $ -150.26M
  • ATAI LIFE SCIENCES NV reached its highest Cons. Inc. over the past 5 years at $ -36.92M.
  • The lowest Cons. Inc. recorded by ATAI LIFE SCIENCES NV in the same timeframe $ -215.85M

ATAI LIFE SCIENCES NV's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
UPB : UPSTREAM BIO INC $ -104.47MKALV : KALVISTA PHARMACEUTICALS INC $ -203.1MVSTM : VERASTEM INC $ -166.56MCNTB : CONNECT BIOPHARMA HOLDINGS LTD $ -46.45MINBX : INHIBRX BIOSCIENCES INC $ -163.69MPROK : PROKIDNEY CORP $ -164.45MSION : SIONNA THERAPEUTICS INC -NTRB : NUTRIBAND INC $ -10.27MORMP : ORAMED PHARMACEUTICALS INC $ -24.22MTRVI : TREVI THERAPEUTICS INC $ -47.3M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ATAI - Consolidated Income, Last 5 years

$ -215.85M

Minimum

Mar 31, 2022

$ -36.92M

Maximum

Mar 31, 2024

$ -137.28M

Average

$ -150.26M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M